4.5 Article

African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses

期刊

VACCINE
卷 36, 期 19, 页码 2694-2704

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2018.03.040

关键词

ASFV; Recombinants; Deletion mutants; LAVs; NH/P68; Armenia07/Arm07

资金

  1. EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU, (DG-Research, EC, 7FP) [KBBE211691]
  2. EU project ASFORCE, Targeted Research Effort on African Swine Fever (DG-Research, EC, 7FP Grant) [KBBE.2012.1.3-02, 311931]
  3. EU [UE-LR PPA/03]

向作者/读者索取更多资源

The risk of spread of African swine fever virus (ASFV) from Russia and Caucasian areas to several EU countries has recently emerged, making it imperative to improve our knowledge and defensive tools against this important pathogen. The ASFV genome encodes many genes which are not essential for virus replication but are known to control host immune evasion, such as NFxB and the NFAT regulator A238L, the apoptosis inhibitor A224L, the MHC-I antigen presenting modulator EP153R, and the A276R gene, involved in modulating type I IFN. These genes are hypothesized to be involved in virulence of the genotype I parental ASFV NH/P68. We here describe the generation of putative live attenuated vaccines (LAV) prototypes by constructing recombinant NH/P68 viruses lacking these specific genes and containing specific markers. (C) 2018 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据